α-Glucosidase inhibitory potential of Oroxylum indicum using molecular docking, molecular dynamics, and in vitro evaluation
Background: According to the International Diabetes Federation, there will be 578 million individuals worldwide with diabetes by 2030 and 700 million by 2045. One of the promising drug targets to fight diabetes is α-glucosidase (AG), and its inhibitors may be used to manage diabetes by reducing the...
Saved in:
Main Authors: | Samhita Bhaumik (Author), Alekhya Sarkar (Author), Sudhan Debnath (Author), Bimal Debnath (Author), Rajat Ghosh (Author), Magdi E.A. Zaki (Author), Sami A. Al-Hussain (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
<i>Parkia javanica</i> Edible Pods Reveal Potential as an Anti-Diabetic Agent: UHPLC-QTOF-MS/MS-Based Chemical Profiling, In Silico, In Vitro, In Vivo, and Oxidative Stress Studies
by: Alekhya Sarkar, et al.
Published: (2024) -
Inhibitory effects against zoonotic bacteria by Oroxylum indicum ointment and effects to dog wound
by: Patchima Sithisarn, et al.
Published: (2024) -
Identification of bioactive compounds by GC-MS and α-amylase and α-glucosidase inhibitory activity of Rauvolfia tetraphylla L. and Oroxylum indicum (L.) Kurz: an in vitro and in silico approach
by: Ananta Swargiary, et al.
Published: (2020) -
An insight into anti-adipogenic properties of an Oroxylum indicum (L.) Kurz extract
by: Tanaporn Hengpratom, et al.
Published: (2020) -
Oroxylum indicum (L.) Kurz extract inhibits adipogenesis and lipase activity in vitro
by: Tanaporn Hengpratom, et al.
Published: (2018)